WallStSmart

Bioceres Crop Solutions Corp (BIOX)vsNutrien Ltd (NTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 10431% more annual revenue ($26.88B vs $255.21M). NTR leads profitability with a 8.9% profit margin vs -96.9%. NTR appears more attractively valued with a PEG of 1.21. NTR earns a higher WallStSmart Score of 67/100 (B-).

BIOX

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 2.0Value: 4.7Quality: 2.5
Piotroski: 3/9Altman Z: 0.63

NTR

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 6.0Value: 5.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BIOX.

NTRSignificantly Overvalued (-31.4%)

Margin of Safety

-31.4%

Fair Value

$55.61

Current Price

$67.20

$11.59 premium

UndervaluedFair: $55.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BIOX2 strengths · Avg: 9.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

NTR4 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

EPS GrowthGrowth
1250.0%10/10

Earnings expanding 1250.0% YoY

P/E RatioValuation
13.7x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
19.0%8/10

19.0% revenue growth

Areas to Watch

BIOX4 concerns · Avg: 3.0/10
PEG RatioValuation
1.954/10

Expensive relative to growth rate

Market CapQuality
$31.30M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-359.8%2/10

ROE of -359.8% — below average capital efficiency

NTR2 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Free Cash FlowQuality
$-1.13B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : BIOX

The strongest argument for BIOX centers on Price/Book, EPS Growth.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, EPS Growth, P/E Ratio. Revenue growth of 19.0% demonstrates continued momentum. PEG of 1.21 suggests the stock is reasonably priced for its growth.

Bear Case : BIOX

The primary concerns for BIOX are PEG Ratio, Market Cap, Piotroski F-Score. Debt-to-equity of 3.55 is elevated, increasing financial risk.

Bear Case : NTR

The primary concerns for NTR are Altman Z-Score, Free Cash Flow.

Key Dynamics to Monitor

BIOX profiles as a turnaround stock while NTR is a growth play — different risk/reward profiles.

NTR carries more volatility with a beta of 1.06 — expect wider price swings.

NTR is growing revenue faster at 19.0% — sustainability is the question.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NTR scores higher overall (67/100 vs 46/100) and 19.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bioceres Crop Solutions Corp

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Bioceres Crop Solutions Corp.

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?